Highlighting the Medico-economic Interest of an Adapted Physical Activity for Haemodialysis Patients

Highlighting the Medico-economic Interest of an Adapted Physical Activity for Haemodialysis Patients

Chronic hemodialysis is often associated with a reduction in the quality of life of patients and a reduction in physical activity, due to the repeated frequency of sessions.

Various studies conducted in hemodialysis patients have shown the beneficial effects of physical exercise during hemodialysis sessions on reducing cardiovascular risk, the number of hospitalizations and improving quality of life. It also contributes to improved patient adherence to care.

Finally, it has been shown that exercise during the hemodialysis session is safe for the patient and does not disrupt dialysis parameters.

Nevertheless, there are no data on the medico-economic impact of such a program.

Based on the investigators' experience, the investigators have developed a specific protocol linking the different types of physical activity that have provided evidence of their efficiency and used in standard practice in the investigators' institutions. From tests and questionnaires assessing the physical abilities of patients have already validated for this population in this pathology.

The objective of this project is to show the medico-economic interest of an adapted physical activity program for hemodialysis patients.

Inclusion Criteria:

• Patient dependent on the CPAM Haute Garonne,
• Patient affiliated to or beneficiary of a French social security scheme,
• Haemodialysis patient for more than 12 months and in front of benefiting/benefiting from a physical activity program,
• Patient age ≥ at 18 years old,
• French speaking patient.

Exclusion Criteria:

• Patient with cancer, hepatitis, stage 4 arterial disease, arteritis or amputation of a limb
• Pregnant or breastfeeding women according to article L.1121-5 of the CSP,
• Vulnerable persons according to article L.1121-6 of the CSP,
• Persons of full age under guardianship or curatorship or under safeguard of justice,
• Patient unable to personally give his or her consent, or age of majority protected by law,
• Opposition expressed to inclusion in the study.